ArticleGastroenterology research2019

Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn's Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center.

Zunirah Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.